Équipe Action

Mise à jour le   13/04/2026

The ACTION team (Therapeutic ACTion guided by multimodality Imaging in ONcology) is one of the four research teams of the LaTIM laboratory (INSERM UMR 1101), under the direction of Prof. Dimitris Visvikis. It focuses on the integration of multimodal imaging technologies (PET, CT, MRI) into therapeutic strategies for oncology.

The team’s ambition is to build a coherent translational research program, from image acquisition and reconstruction to personalized treatment planning and outcome prediction. This is structured around three complementary axes: advanced tomographic reconstruction, multiparametric modeling of tumor characteristics, and personalized dosimetry for radiotherapy. Each axis is led by experienced researchers and closely linked to clinical applications through strong collaborations with hospital partners.

ACTION’s research activities are characterized by the development of innovative computational methods that remain compatible with clinical use, thanks to a strong focus on feasibility, robustness, and interpretability.

This axis focuses on optimizing dosimetry in therapy protocols using imaging, numerical simulation, and various therapy delivery regimes and systems. Key topics include:

  • Patient-specific image-based modeling (Digital Twin): image segmentation, registration and synthesis, use of AI, etc.

  • Synthetic medical image generation: Monte Carlo simulation, genAI, CT, PET, SPECT, etc.

  • Dose calculation: Monte Carlo simulation, GPU-based, AI-based, 

  • Dose optimization: inverse treatment planning, adaptive therapy, etc.
     

Prostate Brachytherapy

  • From diagnostic, through planning to delivery

  • Multimodal image processing (segmentation, registration, etc.)

  • Fast personalized dosimetry

  • Edema biomechanical model

  • Advanced treatment planning system

  • Collaborative robotic guidance

  • Clinical evaluations

prostate

External Beam Radiotherapy

  • Surface Guided

  • On-line and real-time adaptive

  • Non-coplanar

  • Fast dose calculation

  • Inverse planning

  • Mask-free brain delivery

  • Clinical evaluations

external

Interventional Radiology

  • Real-time patient exposure calculation

  • Real-time occupational exposure

  • Inverse planning

  • VR training

  • Clinical evaluations

radiology1
radiology2

Targeted Radionuclide Therapy

  • Metastatic prostate cancer

  • Dose personalization

  • Synthetic image generation (CT, PET, SPECT)

  • Dose Monte Carlo calculation

  • AI-based dose prediction

  • Inverse planning

  • Beta and alpha

therapy

Current Projects

  • LutADose Project, European Union,  PIANOFORTE, personalized dosimetry to improve the clinical outcome of prostate cancer patients treated with 177Lu/225Ac-PSMA targeted therapies
  • DIANA Project, Projets Structurants Pour la Compétitivité (PSPC), BPI France, Démocratiser l’imagerie de fusion dans le cancer de la prostate, Intelligence Artificielle et Imagerie de Nouvelle Génération

Collaboration in Open Source Software 

  • OpenGate: World-wild reference Monte Carlo simulation in Medical Physics, the group is part of the steering committee
  • GGEMS: GPU-based Monte Carlo simulation software, developed by LaTIM

Axis Leader

Julien Bert, Research Engineer

Permanent Members

Chi-Hieu Pham (MCU)

Vincent Bourbonne (MCU-PH)

Ulrike Schick (PU-PH)

Antoine Valeri (PU-PH)

Bahaa Nasr (PU-PH)

Nicolas Boussion, Medical Physicist

Didier Benoit, Research Engineer

Nassib Abdallah, Research Engineer

This axis designs and evaluates methods dedicated to exploitation of multimodal 3D-4D images for knowledge extraction in oncology applications (including lung, liver, cervix, esophagus, head and neck, rectum, and brain tumors), with a focus on the 3 following themes:

  • Low data regimes (i.e., rare cancer, small cohorts specific to sub-types of cancer or patient types, as well as limited available annotations)

  • Generative AI / synthesis methods

  • Interpretability/explainability

Methodological developments focus on:

  • Exploring alternative machine/deep learning (ML/DL) models and associated training approaches better suited small medical imaging oncological datasets, and the development of foundation models

  • Incorporating a priori information (e.g. geometrical or clinical) and constraints  into ML/DL models

  • Generative AI (image synthesis) for e.g., cross-modality or within-modality transforms

  • Interpretability and explainability techniques dedicated to ML/DL for increased trust and reliance by clinician end-users

These focuses are then derived and implemented into the following downstream tasks:

  • Image enhancement

  • Tumors, organs or structures detection and segmentation

  • Longitudinal or dynamic images (handling time dimension)

  • Multicentric harmonization

  • Radiomics and dosiomics (including combination with other types of data)

The targeted clinical applications are:

  • Diagnosis/screening (e.g., differentiate between different tumor subtypes, HPV status, etc.)

  • Surgery planning and post-operative evaluation

  • Follow-up monitoring and prediction of outcomes

Current Projects

  • 2025-2028, Thèse co-tutelle internationale UBO et Université Libanaise, Développement de modèles prédictifs explicables dans des cohortes multicentriques en oncologie
  • 2024-2027, Thèse CIFRE Dosisoft, Dosiomique optimisée pour l’assurance qualité des traitements adaptatifs en radiothérapie externe
  • 2023-2026, Thèse co-tutelle internationale (Ligue contre le cancer et Brest Métropole), "Novel spatial neural networks for explainable and efficient radiomics in oncology"
     

Axis Leaders

Matthieu Hatt, Director of Research, Inserm

Catherine Cheze Le Rest, PU-PH

Permanent Members

Pierre-Henry Conze (MCU)

Vincent Jaouen (MCU)

Vincent Bourbonne (MCU-PH)

Ulrike Schick (PU-PH)

This axis develops new methodologies for tomographic image reconstruction in PET and CT. Our methodological developments include:

  • Fast image reconstruction algorithms.

  • Unsupervised learning for image priors.

This techniques are developed for low-dose and low-statistic imaging, with applications including:

CT-less PET reconstruction

  • Joint estimation of the activity and the attenuation from emission data only
  • Utilisation of diffusion models for ultra low-dose imaging (Phung et al., 2025)
ctless

Motion-compensated CT

  • Joint image reconstruction and motion estimation
  • Utilisation of diffusion models forlow-dose  sparse-view CT (De Paepe et al., 2025)
motion

Spectral CT material decomposition

  • One-step material decomposition from spectral data

  • Utilisation of diffusion models for ultra low-dose imaging (Vazia et al., 2025)

spectral

Other research areas

  • 3-gamma PET reconstruction

  • Positron range correction

  • Scatter correction

Current Projects

  • 2024-2027, PhD Thesis, DeepMove – deep learning for motion-compensated CT reconstruction
  • 2024-2027, PhD Thesis, Motion-corrected Ultra low-dose PET with Diffusion models
  • 2023-2027, PhD Thesis, Mat-DPS – Material decomposition with diffusion posterior sampling
  • 2020-2025, National Collaboration, MultiRecon – Machine Learning for Multimodal Medical Image Reconstruction

Axis Leader

Alexandre Bousse, Inserm Researcher, Inserm

Permanent Members

Catherine Cheze Le Rest, PU-PH

Thibaut Merlin, Research Engineer

Baptiste Laurent, Research Engineer

Dimitris Visvikis, Director of Reseach, Inserm

Contacts